NSABP Patient Registry and Biospecimen Profiling Repository
Public ClinicalTrials.gov record NCT01793805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to collect and analyze tissue specimens from metastatic colorectal cancer (mCRC) patients for the development of a molecularly profiled tissue repository for the primary purpose of maintaining a patient registry for future clinical trials based on the molecular profile of the tumors. The main purpose of testing these tissue specimens is to identify genetic alterations or biomarkers associated with colorectal cancer such that if new agent(s) become available, particularly those that target these genetic alterations/biomarkers, participants may be offered the opportunity to take part in a National Surgical Adjuvant Breast and Bowel Project (NSABP) treatment protocol.
Study identification
- NCT ID
- NCT01793805
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 3,232 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- Feb 28, 2022
- Completion
- Feb 28, 2022
- Last update posted
- Mar 30, 2022
2013 – 2022
United States locations
- U.S. sites
- 46
- U.S. states
- 19
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | — |
| Kaiser Permanente-San Diego | San Diego | California | 92120 | — |
| Kaiser Permanente-Vallejo | Vallejo | California | 94589 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Baptist Cancer Institute - Jacksonville | Jacksonville | Florida | 32207 | — |
| UF Cancer Center at Orlando Health | Orlando | Florida | 32806 | — |
| Memorial University Medical Center | Savannah | Georgia | 31404 | — |
| St. Luke's Mountain States Tumor Institute - Boise | Boise | Idaho | 83712 | — |
| Kootenai Health Cancer Services | Post Falls | Idaho | 83854 | — |
| Decatur Memorial Hospital | Decatur | Illinois | 62526 | — |
| CCOP - Northern Indiana CR Consortium | South Bend | Indiana | 46601 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Medstar Franklin Square Medical Center, Weinberg Cancer Institute | Baltimore | Maryland | 21237 | — |
| Holy Cross Hospital | Silver Spring | Maryland | 20910 | — |
| CCOP - Michigan Cancer Research Consortium | Ann Arbor | Michigan | 48106 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Cancer Research Consortium of West Michigan | Grand Rapids | Michigan | 49503 | — |
| CCOP, Kalamazoo, MI | Kalamazoo | Michigan | 49007 | — |
| CCOP - Metro-Minnesota | Saint Louis Park | Minnesota | 55416 | — |
| CCOP - Missouri Valley Cancer Consortium | Omaha | Nebraska | 68131 | — |
| Randolph Hospital | Asheboro | North Carolina | 27203 | — |
| Mission Hospitals | Asheville | North Carolina | 28801 | — |
| Carolinas Medical Center/Levine Cancer Center | Charlotte | North Carolina | 28203 | — |
| Presbyterian Hospital | Charlotte | North Carolina | 28233 | — |
| Wayne Memorial Hospital | Goldsboro | North Carolina | 27534 | — |
| CCOP - Cone Health Cancer Center | Greensboro | North Carolina | 27403 | — |
| High Point Regional Hospital | High Point | North Carolina | 27261 | — |
| FirstHealth of the Carolinas-Moore Regional Hosiptal | Pinehurst | North Carolina | 28374 | — |
| Annie Penn Memorial Hospital | Reidsville | North Carolina | 27320 | — |
| CCOP Forsyth Memorial Hospital | Winston-Salem | North Carolina | 27103 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| Sanford Medical Center | Fargo | North Dakota | 58122 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Allegheny General Hospital/Allegheny-Singer Research Institute | Pittsburgh | Pennsylvania | 15212 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Reading Hospital and Medical Center | West Reading | Pennsylvania | 19611 | — |
| Roper Hospital | Charleston | South Carolina | 29401 | — |
| Cancer Centers of the Carolinas (International) | Greenville | South Carolina | 29615 | — |
| CCOP - Sanford Research | Sioux Falls | South Dakota | 57104 | — |
| Wellmont Holston Valley Hospital and Medical Center | Kingsport | Tennessee | 37660 | — |
| Virginia Oncology Associates - Hampton | Hampton | Virginia | 23666 | — |
| MBCCOP, Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| CCOP, St. Vincent Hospital | Green Bay | Wisconsin | 54301 | — |
| CCOP, Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
| Aurora Health Care | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Colorectal Cancer trials
Other public records listing Colorectal Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07403981: Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients Recruiting
- NCT00001823: Evaluation for NCI Surgery Branch Clinical Research Protocols Recruiting
- NCT07796334: Colon Health Champion Program Not yet recruiting
- NCT07071961: Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] Recruiting
- NCT07781852: Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer Not yet recruiting
- NCT07781774: Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01793805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2022 · Synced Sep 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01793805 live on ClinicalTrials.gov.